0243.KLSE Cengild Medical Berhad

Healthcare Biotechnology Kuala Lumpur Exchange
0.1600 MYR
Close of Oct 29, 2026
0.1550 0.2360
Market cap
MYR 133M
P/E
16.0x
P/B
1.15x
ROE
9.5%
Dividend yield
4.37%
Fundamental score
2.5/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is 0243.KLSE undervalued?

Graham number
Price0.1600
Graham value0.1773
Discount9.8%

0243.KLSE trades 9.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cengild Medical Berhad fundamental analysis

13 of 22 checks passed

ROE 0/2

Low return on equity (9.5%), below 10%.

ROA 1/1

Return on assets (5.1%) is above the industry median (-19.8%).

Profit Consistency 2/2

Profitable for 7 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (3.5%) is above the 5-year average (2.4% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (3.5%) is below the industry median (3.8%).

Revenue Growth 1/2

Revenue grew 1.4% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 1/2

Moderate debt to equity (69.6%), up to 100%.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 1/1

EBIT is 75.3x against interest expense, well covered.

PE vs Market 0/1

PE (16.0x) is above the market median (11.4x).

PE vs Industry 1/1

PE (16.0x) is below the industry median (18.6x).

PBV 1/1

Price to book (1.1x) is below the industry median (3.1x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 18.3, limit 22.5).

PEG 0/1

PEG on 5-year earnings growth is 6.76, above 1.

Dividend Yield 1/2

Dividend yield (4.4%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 51.0%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About Cengild Medical Berhad

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiology; ear, nose and throat; gastrointestinal surgeries, including upper gastrointe…

Full company profile